Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
SÜDPACK is setting standards in terms of both performance and sustainability
Gafchromic films support patient care in oncology
Several late-stage pipeline products have the potential to address some of these unmet needs
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
To enable company to be future-ready by tapping potential in CDMO space
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
Subscribe To Our Newsletter & Stay Updated
